Charles River Laboratories International, Inc. (CRL)
USD 166.63
(-4.85%)
USD 166.63
(-4.85%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 617.26 Million USD | -5.18% |
| 2022 | 650.97 Million USD | 10.36% |
| 2021 | 589.86 Million USD | 36.31% |
| 2020 | 432.72 Million USD | 23.23% |
| 2019 | 351.15 Million USD | 5.97% |
| 2018 | 331.38 Million USD | 15.26% |
| 2017 | 287.49 Million USD | 21.09% |
| 2016 | 237.41 Million USD | 15.0% |
| 2015 | 206.44 Million USD | 16.2% |
| 2014 | 177.67 Million USD | 17.35% |
| 2013 | 151.4 Million USD | -8.67% |
| 2012 | 165.76 Million USD | -4.9% |
| 2011 | 174.3 Million USD | 158.39% |
| 2010 | -298.51 Million USD | -278.83% |
| 2009 | 166.92 Million USD | 137.11% |
| 2008 | -449.76 Million USD | -297.97% |
| 2007 | 227.19 Million USD | 20.74% |
| 2006 | 188.17 Million USD | 3.95% |
| 2005 | 181.01 Million USD | 12.91% |
| 2004 | 160.32 Million USD | 15.71% |
| 2003 | 138.55 Million USD | 13.32% |
| 2002 | 122.26 Million USD | 35.43% |
| 2001 | 90.28 Million USD | 38.77% |
| 2000 | 65.06 Million USD | 51.43% |
| 1999 | 42.96 Million USD | 21.62% |
| 1998 | 35.32 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 169.6 Million USD | 18.63% |
| 2024 Q1 | 142.97 Million USD | 7.56% |
| 2023 Q4 | 132.92 Million USD | -12.26% |
| 2023 Q3 | 151.5 Million USD | -8.15% |
| 2023 Q2 | 164.94 Million USD | -1.76% |
| 2023 FY | 617.26 Million USD | -5.18% |
| 2023 Q1 | 167.89 Million USD | -39.97% |
| 2022 Q1 | 148.77 Million USD | -13.91% |
| 2022 Q3 | 150.97 Million USD | -20.02% |
| 2022 Q4 | 279.7 Million USD | 85.26% |
| 2022 FY | 650.97 Million USD | 10.36% |
| 2022 Q2 | 188.77 Million USD | 26.88% |
| 2021 Q3 | 155.8 Million USD | 13.27% |
| 2021 Q1 | 123.7 Million USD | -4.05% |
| 2021 Q4 | 172.8 Million USD | 10.91% |
| 2021 FY | 589.86 Million USD | 36.31% |
| 2021 Q2 | 137.55 Million USD | 11.19% |
| 2020 Q2 | 76.76 Million USD | -18.58% |
| 2020 FY | 432.72 Million USD | 23.23% |
| 2020 Q4 | 128.92 Million USD | -2.88% |
| 2020 Q3 | 132.75 Million USD | 72.93% |
| 2020 Q1 | 94.28 Million USD | -13.34% |
| 2019 Q4 | 108.78 Million USD | 17.23% |
| 2019 Q1 | 69.79 Million USD | -31.9% |
| 2019 Q2 | 79.76 Million USD | 14.29% |
| 2019 Q3 | 92.8 Million USD | 16.34% |
| 2019 FY | 351.15 Million USD | 5.97% |
| 2018 FY | 331.38 Million USD | 15.26% |
| 2018 Q3 | 84.36 Million USD | 9.98% |
| 2018 Q4 | 102.48 Million USD | 21.48% |
| 2018 Q2 | 76.71 Million USD | 13.09% |
| 2018 Q1 | 67.82 Million USD | 8.13% |
| 2017 Q3 | 73.98 Million USD | -9.01% |
| 2017 Q2 | 81.31 Million USD | 17.04% |
| 2017 Q1 | 69.47 Million USD | 0.55% |
| 2017 Q4 | 62.73 Million USD | -15.21% |
| 2017 FY | 287.49 Million USD | 21.09% |
| 2016 Q4 | 69.09 Million USD | 17.51% |
| 2016 Q1 | 51.47 Million USD | -1.52% |
| 2016 Q3 | 58.79 Million USD | 1.26% |
| 2016 Q2 | 58.06 Million USD | 12.8% |
| 2016 FY | 237.41 Million USD | 15.0% |
| 2015 FY | 206.44 Million USD | 16.2% |
| 2015 Q1 | 43 Million USD | 5.49% |
| 2015 Q2 | 55.73 Million USD | 29.6% |
| 2015 Q3 | 55.44 Million USD | -0.53% |
| 2015 Q4 | 52.26 Million USD | -5.72% |
| 2014 Q2 | 51.02 Million USD | 28.51% |
| 2014 Q4 | 40.76 Million USD | -11.71% |
| 2014 FY | 177.67 Million USD | 17.35% |
| 2014 Q1 | 39.7 Million USD | 61.36% |
| 2014 Q3 | 46.17 Million USD | -9.51% |
| 2013 FY | 151.4 Million USD | -8.67% |
| 2013 Q4 | 24.6 Million USD | -39.75% |
| 2013 Q3 | 40.84 Million USD | -5.43% |
| 2013 Q2 | 43.18 Million USD | 0.99% |
| 2013 Q1 | 42.76 Million USD | 21.94% |
| 2012 Q2 | 49.27 Million USD | 12.65% |
| 2012 FY | 165.76 Million USD | -4.9% |
| 2012 Q3 | 37.68 Million USD | -23.53% |
| 2012 Q1 | 43.74 Million USD | 5.03% |
| 2012 Q4 | 35.06 Million USD | -6.93% |
| 2011 Q1 | 42.25 Million USD | 111.69% |
| 2011 Q2 | 53.31 Million USD | 26.18% |
| 2011 Q3 | 37.09 Million USD | -30.42% |
| 2011 Q4 | 41.64 Million USD | 12.27% |
| 2011 FY | 174.3 Million USD | 158.39% |
| 2010 Q2 | 28.2 Million USD | -4.4% |
| 2010 FY | -298.51 Million USD | -278.83% |
| 2010 Q1 | 29.5 Million USD | -7.59% |
| 2010 Q3 | 5.11 Million USD | -81.87% |
| 2010 Q4 | -361.33 Million USD | -7166.91% |
| 2009 FY | 166.92 Million USD | 137.11% |
| 2009 Q1 | 39.89 Million USD | 106.13% |
| 2009 Q2 | 50.66 Million USD | 26.99% |
| 2009 Q3 | 44.44 Million USD | -12.27% |
| 2009 Q4 | 31.92 Million USD | -28.18% |
| 2008 Q4 | -650.79 Million USD | -1054.09% |
| 2008 FY | -449.76 Million USD | -297.97% |
| 2008 Q3 | 68.21 Million USD | -1.6% |
| 2008 Q2 | 69.32 Million USD | 9.17% |
| 2008 Q1 | 63.5 Million USD | 21.8% |
| 2007 Q2 | 56.72 Million USD | 3.7% |
| 2007 FY | 227.19 Million USD | 20.74% |
| 2007 Q1 | 54.7 Million USD | 21.14% |
| 2007 Q3 | 63.63 Million USD | 12.17% |
| 2007 Q4 | 52.13 Million USD | -18.07% |
| 2006 Q4 | 45.15 Million USD | -13.03% |
| 2006 Q1 | -84.96 Million USD | -334.22% |
| 2006 Q2 | 47.7 Million USD | 156.14% |
| 2006 FY | 188.17 Million USD | 3.95% |
| 2006 Q3 | 51.92 Million USD | 8.84% |
| 2005 Q1 | 45.39 Million USD | 36.62% |
| 2005 Q2 | 49.85 Million USD | 9.82% |
| 2005 Q3 | 49.49 Million USD | -0.72% |
| 2005 Q4 | 36.27 Million USD | -26.71% |
| 2005 FY | 181.01 Million USD | 12.91% |
| 2004 FY | 160.32 Million USD | 15.71% |
| 2004 Q1 | 39.51 Million USD | 11.49% |
| 2004 Q2 | 44.2 Million USD | 11.86% |
| 2004 Q3 | 43.37 Million USD | -1.88% |
| 2004 Q4 | 33.22 Million USD | -23.39% |
| 2003 FY | 138.55 Million USD | 13.32% |
| 2003 Q3 | 34.25 Million USD | -2.14% |
| 2003 Q4 | 35.44 Million USD | 3.47% |
| 2003 Q1 | 33.84 Million USD | 9.35% |
| 2003 Q2 | 35 Million USD | 3.42% |
| 2002 Q4 | 30.95 Million USD | -4.81% |
| 2002 Q3 | 32.51 Million USD | 7.03% |
| 2002 Q2 | 30.38 Million USD | 6.94% |
| 2002 Q1 | 28.41 Million USD | 26.8% |
| 2002 FY | 122.26 Million USD | 35.43% |
| 2001 Q1 | 19.37 Million USD | 40.72% |
| 2001 FY | 90.28 Million USD | 38.77% |
| 2001 Q4 | 22.4 Million USD | -6.69% |
| 2001 Q3 | 24.01 Million USD | -1.96% |
| 2001 Q2 | 24.49 Million USD | 26.42% |
| 2000 FY | 65.06 Million USD | 51.43% |
| 2000 Q4 | 13.76 Million USD | -22.86% |
| 2000 Q3 | 17.84 Million USD | -2.0% |
| 2000 Q1 | 15.23 Million USD | 0.0% |
| 2000 Q2 | 18.21 Million USD | 19.57% |
| 1999 FY | 42.96 Million USD | 21.62% |
| 1998 FY | 35.32 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Agilent Technologies, Inc. | 1.35 Billion USD | 54.277% |
| Quest Diagnostics Incorporated | 1.26 Billion USD | 51.089% |
| Danaher Corporation | 5.2 Billion USD | 88.134% |
| Enzo Biochem, Inc. | -9.81 Million USD | 6387.674% |
| IQVIA Holdings Inc. | 1.97 Billion USD | 68.778% |
| Laboratory Corporation of America Holdings | 725.6 Million USD | 14.931% |
| Mettler-Toledo International Inc. | 1.15 Billion USD | 46.413% |
| Qiagen N.V. | 445.24 Million USD | -38.633% |
| Revvity, Inc. | 300.56 Million USD | -105.369% |
| Thermo Fisher Scientific Inc. | 6.85 Billion USD | 91.001% |
| Waters Corporation | 817.67 Million USD | 24.51% |